Status:
RECRUITING
Prevention and Treatment of AKI VEXUS Guided Post Cardiac Surgery
Lead Sponsor:
Onassis Cardiac Surgery Centre
Conditions:
Acute Kidney Injury
Cardiac Surgery Associated - Acute Kidney Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main goal of this clinical trial is to learn if evaluation by ultrasound of venous congestion of liver and kidneys can guide treatment and prevent and treat acute kidney injury post cardiac surger...
Detailed Description
Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common and serious complication, with an incidence of up to 40% in cardiac surgery...
Eligibility Criteria
Inclusion
- Patients in the Cardiac Surgery ICU who develop acute kidney injury according to KDIGO criteria, within 48 hours of ICU admission after cardiac surgery
- Elective and non-elective cardiac surgery.
Exclusion
- Patient refusal
- Severe chronic renal failure (GFR\<15 mL/min/m2 or on hemodialysis).
- Critical preoperative condition (severe cardiogenic shock, resuscitated cardiac arrest, support with mechanical circulatory assist devices).
- Liver cirrhosis or inferior vena cava obstruction.
- Pregnancy.
- Morbid obesity (BMI\>40 kg/m2).
- Delirium or other condition that prevents the performance of an ultrasound study.
Key Trial Info
Start Date :
June 29 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT06972082
Start Date
June 29 2023
End Date
October 1 2025
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Onassis Cardiac Surgery Center
Athens, Kallithea, Greece, 17674